Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Insulin-like growth factor pathway-targeted therapy in breast cancer
Saad J. Sirop
, Paul Haluska
Hematology
Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Insulin-like growth factor pathway-targeted therapy in breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
Insulin-like
100%
Growth Factor Pathway
100%
Pathway-targeted Therapy
100%
Cancer Resistance
25%
Malignancy
12%
Preclinical Data
12%
Tumor Growth
12%
Metastasis
12%
Poor Prognosis
12%
Growth Factor Signaling
12%
Clinical Data
12%
Cancer Mechanisms
12%
Estrogen Pathway
12%
Cancer-specific Survival
12%
HER2-targeted Therapy
12%
Cancer Development
12%
Potential Interaction
12%
Clinical Development
12%
Resistance to Therapy
12%
Role in Cancer
12%
Ongoing Clinical Trials
12%
Tumor Resistance
12%
ErbB
12%
Antineoplastic Drugs
12%
MTOR Pathway
12%
Breast Cancer Data
12%
Novel Anticancer Therapies
12%
Medicine and Dentistry
Targeted Therapy
100%
Breast Cancer
100%
Somatomedin
100%
Malignant Neoplasm
12%
Clinical Trial
12%
Cancer
12%
Tumor Progression
12%
Metastatic Carcinoma
12%
Mammalian Target of Rapamycin
12%
Cancer Treatment
12%
Cancer Resistance
12%
Tumor Resistance
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Somatomedin
100%
Clinical Trial
12%
Malignant Neoplasm
12%
Tumor Growth
12%
Cancer Resistance
12%
Tumor Resistance
12%